Buy Evista through the unique service that maximize your savings

Eli Lilly and Co. says that the FDA has granted a priority review for the supplemental new drug application for an osteoporosis indication for Evista. The drug has been on the market since January 1998 for use in preventing osteoporosis in postmeno…